Skip to search formSkip to main contentSkip to account menu

IDEC-Y2B8

Known as: IDEC Y2B8, IDEC-Y2B8 Monoclonal Antibody 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ibritumomab tiuxetanyttrium-90-ibritumomab tiuxetan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
FRI0580 Comorbidity Burden and Medication Use between Psoriatic Arthritis Patients with Moderate-To-Severe Psoriasis vs. Those with Minimal Skin Psoriasis in The US
Background Psoriatic arthritis (PsA) is often presented with psoriasis (PsO). However, the severity of PsO among PsA patients… 
Review
2016
Review
2016
Disease Progression Modeling: Key Concepts and Recent Developments
Disease modeling involves the use of mathematical functions to describe quantitatively the time course of disease progression. In… 
2014
2014
An Increase in B cell and Cytotoxic NK cell Proportions and Increased T cell Responsiveness in Blood of Natalizumab-treated Multiple Sclerosis Patients
Background: Changes in the blood lymphocyte composition probably both mediate and reflect the effects of natalizumab treatment in… 
2014
2014
FRI0439 Urinary Collagen Fragments Are Reduced in Lupus Nephritis Subjects with Renal Dysfunction
Background Interstitial fibrosis is a key component of chronic kidney injury in lupus nephritis (LN) and a critical determinant… 
Highly Cited
2013
Highly Cited
2013
Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
It is unclear how cognitive impairment in multiple sclerosis (MS) is influenced by physical disability, fatigue, and depression… 
2013
2013
Immunohistochemical Staining of rFVIIIFc and rFVIII in Liver Cells Differentiates Between a VWF-Dependent and Independent Clearance Pathway in Mice
Introduction rFVIIIFc is a fully recombinant fusion protein consisting of a single B domain-deleted human FVIII covalently… 
2012
2012
Stromedix acquisition signals growing interest in fibrosis
375 by establishing a biomarker strategy. Lungcell samples will be analyzed for markers of TGF-b activity at baseline and during… 
Review
2012
Review
2012
Final Results from the AVONEX(R) (Intramuscular Interferon Beta-1a) Pregnancy Exposure Registry (P06.191)
Objective: To prospectively record and analyze pregnancy outcomes in women with multiple sclerosis (MS) who were exposed to… 
2012
2012
Novel Interventions with Favorable Resolution of Natalizumab-Induced Progressive Multifocal Leukoencephalopathy (PML) (P07.062)
Objective: To describe the outcomes of early detected progressive multifocal leukoencephalopathy (PML) in natalizumab-treated… 
Highly Cited
2011
Highly Cited
2011
Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)